Recycling metchnikoff: probiotics, the intestinal microbiome and the quest for long life.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3859987)

Published in Front Public Health on November 13, 2013

Authors

Philip A Mackowiak1

Author Affiliations

1: Medical Care Clinical Center, VA Maryland Health Care System , Baltimore, MD , USA ; Department of Medicine, University of Maryland School of Medicine , Baltimore, MD , USA.

Associated clinical trials:

Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects | NCT03494725

Articles citing this

Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway. Nat Commun (2017) 1.39

Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health (2014) 1.05

Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2016) 0.91

Human milk: mother nature's prototypical probiotic food? Adv Nutr (2015) 0.88

The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc (2015) 0.86

Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol (2016) 0.81

Gut microbiota: Microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol (2015) 0.79

Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. J Nutr (2017) 0.77

Toward a microbial Neolithic revolution in buildings. Microbiome (2016) 0.75

Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Trials (2016) 0.75

Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer? Front Microbiol (2016) 0.75

A Journey with Elie Metchnikoff: From Innate Cell Mechanisms in Infectious Diseases to Quantum Biology. Front Public Health (2016) 0.75

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. Front Microbiol (2017) 0.75

Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance. Front Microbiol (2017) 0.75